+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Genitourinary Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Genitourinary Collaboration and Licensing Deals 2016-2026

  • Report
  • October 2026
  • 200 Pages
  • Global
From
Endometriosis Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Endometriosis Treatment Market Report and Forecast 2024-2032

  • Report
  • July 2024
  • 200 Pages
  • Global
From
From
Dermatology Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Dermatology Collaboration and Licensing Deals 2016-2026

  • Report
  • October 2026
  • 300 Pages
  • Global
From
Chronic Kidney Disease: Global Markets and Technologies - Product Thumbnail Image

Chronic Kidney Disease: Global Markets and Technologies

  • Report
  • May 2026
  • 152 Pages
  • Global
From
Asthma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • November 2026
  • 372 Pages
  • Global
From
From
From
From
Diabetic Neuropathy Market Report and Forecast 2023-2031 - Product Thumbnail Image

Diabetic Neuropathy Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
Lung Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Lung Cancer Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 373 Pages
  • Global
From
Lymphoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Lymphoma Therapeutics - Global Strategic Business Report

  • Report
  • November 2026
  • 435 Pages
  • Global
From
Loading Indicator